about
Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participantsEffects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicityJuvenile onset Huntington's disease--clinical and research perspectives.Protein misfolding and disease; protein refolding and therapy.Huntington disease (chorea) in the middle East.Transcriptional dysregulation of inflammatory/immune pathways after active vaccination against Huntington's diseaseAnimal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia.Huntington's disease: pathological mechanisms and therapeutic strategies.Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.Structure of a single-chain Fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppression.Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.Tryptophan metabolism and oxidative stress in patients with Huntington's disease.Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease.Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease
P2860
Q30435217-A415250C-7656-4373-9A5D-E78F19F98ED0Q33894812-66AD35D5-1978-4225-8518-C1FCEC81B5AFQ34091006-B9E731F5-63A9-4249-A908-7FA23892BA6FQ34286115-E8272207-A5FB-4E8F-ACA5-A87C472390EAQ34782712-95C33E49-8167-4E7D-B96C-7726FDD8C330Q36142398-71A0F816-7896-4DBD-A0AD-B1BEE902C4BEQ36606399-5D3719A8-7DF4-4C17-AF3F-E8E1C067ADB8Q36793909-C0E997C3-2E48-4DAE-944C-E029EA5BA1F8Q36822322-419FEEE7-5AA8-4388-A9C4-C4BA8898F2F0Q37892975-E27913C3-479F-4443-BE91-48FD4A6C1B17Q41518158-F524B79E-CDF1-442C-8E06-915D262BFD94Q42228159-86B4A659-178E-495C-88C8-CAB94BA8CAECQ42461712-09D3AEB8-6454-4D7F-83AB-D5754B77F492Q45296591-08811D5B-42EC-4E94-90C1-E8A70EE5343DQ45301002-E0863AFA-75CB-44CE-9D86-519D819A021BQ58041298-4C3F2BF0-767B-4FE3-9A45-5B4D677A36FE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transgenic models of Huntington's disease
@ast
Transgenic models of Huntington's disease
@en
Transgenic models of Huntington's disease
@nl
type
label
Transgenic models of Huntington's disease
@ast
Transgenic models of Huntington's disease
@en
Transgenic models of Huntington's disease
@nl
prefLabel
Transgenic models of Huntington's disease
@ast
Transgenic models of Huntington's disease
@en
Transgenic models of Huntington's disease
@nl
P2093
P2860
P356
P1476
Transgenic models of Huntington's disease
@en
P2093
K Sathasivam
L Mangiarini
M Turmaine
S W Davies
P2860
P356
10.1098/RSTB.1999.0447
P407
P577
1999-06-29T00:00:00Z